Compare HNNA & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HNNA | DRIO |
|---|---|---|
| Founded | 1989 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.4M | 82.2M |
| IPO Year | N/A | N/A |
| Metric | HNNA | DRIO |
|---|---|---|
| Price | $10.08 | $12.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $50.00 |
| AVG Volume (30 Days) | 8.3K | ★ 29.7K |
| Earning Date | 12-03-2025 | 11-13-2025 |
| Dividend Yield | ★ 5.34% | N/A |
| EPS Growth | ★ 38.04 | N/A |
| EPS | ★ 1.27 | N/A |
| Revenue | ★ $35,538,000.00 | $24,732,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $20.02 |
| P/E Ratio | $7.93 | ★ N/A |
| Revenue Growth | ★ 19.88 | 7.29 |
| 52 Week Low | $8.43 | $5.94 |
| 52 Week High | $13.88 | $31.00 |
| Indicator | HNNA | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 55.08 | 51.51 |
| Support Level | $9.84 | $11.77 |
| Resistance Level | $10.42 | $12.54 |
| Average True Range (ATR) | 0.33 | 0.94 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 87.61 | 43.70 |
Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced, and fixed income products. It also provides investment advisory services and shareholder services to the Hennessy Funds which include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities as per the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.